In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators

Risultato della ricerca: Articlepeer review

15 Citazioni (Scopus)


One of the major problems in the fight against cancer is drug-resistance, which, at a molecular level, can be acquired through mutations able to deactivate apoptosis. In particular, proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-xl and Bcl-2, are overexpressed in many tumours. The development of new inhibitors of these proteins as potential anticancer therapeutics represents a new frontier. In this work, we carried out an in-silico screening of compounds from a free database of more than 2 million structures (ZINC database), which allowed us to identify 17 sulfonamide derivatives as new potential inhibitors; these are currently undergoing biological evaluation.
Lingua originaleEnglish
pagine (da-a)349-355
Numero di pagine7
RivistaJournal of Molecular Modeling
Stato di pubblicazionePublished - 2009

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.1500.1503???
  • ???subjectarea.asjc.1700.1706???
  • ???subjectarea.asjc.1600.1606???
  • ???subjectarea.asjc.1600.1605???
  • ???subjectarea.asjc.1700.1703???
  • ???subjectarea.asjc.1600.1604???


Entra nei temi di ricerca di 'In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators'. Insieme formano una fingerprint unica.

Cita questo